Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
World Journal of Urology
Erschienen in: World Journal of Urology 1/2006

01.02.2006 | Topic Paper

Probiotics to prevent urinary tract infections: the rationale and evidence

verfasst von: Gregor Reid, Andrew W. Bruce

Erschienen in: World Journal of Urology | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Abstract

For over 30 years, urologists have recognized in females, that urinary pathogens almost always infect the host through ascension from the rectum, vagina to the urethra and bladder. Likewise, the Lactobacillus organisms that predominate in the vagina of healthy women, spread from the rectum and perineum and form a barrier in the vagina to bladder entry by uropathogens. The concept of artificially boosting the lactobacilli numbers through probiotic instillation has long been conceived, but only in recent years shown to be possible. Not all lactobacilli are effective, and to date clinical efficacy only exists for Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri B-54 and RC-14. These strains are only commercially available in Austria, and therefore for most urologists, while some probiotic organisms may reduce the recurrences of bladder cancer or oxaluria, no probiotics can be recommended widely to prevent UTI at present.
Literatur
1.
Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ (2003) Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105-107CrossRefPubMed
2.
Antonio MA, Rabe LK, Hillier SL (2005) Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 192(3):394–398PubMedCrossRef
3.
Asahara T, Nomoto K, Watanuki M, Yokokura T (2001) Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 45(6):1751–1760CrossRefPubMed
4.
Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S (1995) Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 27(2):104–109PubMed
5.
6.
Baerheim A, Larsen E, Digranes A (1994) Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care 12:239–243PubMedCrossRef
7.
Bruce AW, Reid G (2003) Probiotics and the urologist. Can J Urol 10(2):1785–1789PubMed
8.
Bruce AW, Chadwick P, Hassan A, VanCott GF (1973) Recurrent urethritis in women. Can Med Assoc J 108:973–976PubMed
9.
Brumfitt W, Hamilton-Miller JM (1998) Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years’ experience. J Antimicrob Chemother 42:363–371CrossRefPubMed
10.
Brumfitt W, Hamilton-Miller JM, Gargan RA, Cooper J, Smith GW (1983) Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone–iodine. J Urol 130:1110–1114PubMed
11.
Brumfitt W, Hamilton-Miller JM, Walker S, Roberts D (1992) Cefaclor as a prophylactic agent for recurrent urinary infections: a comparative trial with macrocrystalline nitrofurantoin. Drugs Exp Clin Res 18:239–244PubMed
12.
Cadieux P, Burton J, Gardiner G, Braunstein I, Bruce AW, Kang CY, Reid G. (2002) Lactobacillus strains and vaginal ecology. JAMA 287:1940–1941CrossRefPubMed
13.
Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60(3):1097–1105CrossRefPubMed
14.
Cauci S, Guaschino S, De Aloysio D, Driussi S, De Santo D, Penacchioni P, Quadrifoglio F (2003) Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod 9(1):53–58PubMedCrossRef
15.
Cauci S, McGregor J, Thorsen P, Grove J, Guaschino S (2005) Combination of vaginal pH with vaginal sialidase and prolidase activities for prediction of low birth weight and preterm birth. Am J Obstet Gynecol 192(2):489–496CrossRefPubMed
16.
Chan RC, Bruce AW, Reid G (1984) Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion. J Urol 131(3):596–601PubMed
17.
Colodner R, Edelstein H, Chazan B, Raz R (2003) Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J 5(11):767–769PubMed
18.
Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82(2):103–108PubMedCrossRef
19.
Darouiche RO, Thornby JI, Cerra-Stewart C, Donovan WH, Hull RA (2005) Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 41(10):1531–1534CrossRefPubMed
20.
Fraga M, Scavone P, Zunino P (2005) Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model. Antonie Van Leeuwenhoek 88(1):25–34CrossRefPubMed
21.
Gower PR, Roberts AP (1975) Qualitative assessment of midstream urine cultures in the detection of bacteriuria. Clin Nephrol 3(1):10–13PubMed
22.
Hagberg LA, Bruce AW, Reid G, Svanborg Eden C, Lincoln K, Lidin-Janson G (1989) Colonization of the urinary tract with live bacteria from the normal fecal and urethral flora in patients with recurrent symptomatic urinary tract infections. In: Kass EH, Eden C Svanborg (eds) Host–parasite interactions in urinary tract infections. University of Chicago Press, Chicago, pp 194–197
23.
Hopkins WJ, Uehling DT (2002) Vaccine development for the prevention of urinary tract infections. Curr Infect Dis Rep 4(6):509–513PubMedCrossRef
24.
Kazhina MV, Zhmakin AI, Titov LP (2005) Changes in vaginal microbiocenosis in patients with chronic pelvic inflammatory diseases following antibiotic therapy. Zh Mikrobiol Epidemiol Immunobiol May–June (3):75–78
25.
Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M (2001) Randomised trial of cranberry–lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 322:1571CrossRefPubMed
26.
Kontiokari T, Laitinen J, Jarvi L, Pokka T, Sundqvist K, Uhari M (2003) Dietary factors protecting women from urinary tract infection. Am J Clin Nutr 77(3):600–604PubMed
27.
Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115(1):178–181PubMed
28.
Lane MC, Lockatell V, Monterosso G, Lamphier D, Weinert J, Hebel JR, Johnson DE, Mobley HL (2005) Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun 73(11):7644–7656CrossRefPubMed
29.
Langermann S, Ballou WR (2003) Development of a recombinant FimCH vaccine for urinary tract infections. Adv Exp Med Biol 539(Pt B):635–648PubMed
30.
Laughton J, Devillard E, Heinrichs DE, Reid G, McCormick JK (2004) Cell–cell communication in Gram-positive bacteria: Inhibition of Staphylococcus aureus exotoxin expression by Lactobacillus reuteri. In: American Society for Microbiology Conference on cell–cell communication, Banff, Alberta, July (Abstract)
31.
Li X, Lockatell CV, Johnson DE, Lane MC, Warren JW, Mobley HL (2004) Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect Immun 72(1):66–75CrossRefPubMed
32.
Marrs CF, Zhang L, Foxman B (2005) Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes? FEMS Microbiol Lett 252(2):183–190CrossRefPubMed
33.
Morelli L, Zonenenschain D, Del Piano M, Cognein P (2004) Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol 38(6 Suppl):S107–S110CrossRefPubMed
34.
Ocana VS, Elena Nader-Macias M (2004) Production of antimicrobial substances by lactic acid bacteria II: screening bacteriocin-producing strains with probiotic purposes and characterization of a Lactobacillus bacteriocin. Methods Mol Biol 268:347–353PubMed
35.
Osset J, Bartolome RM, Garcia E, Andreu A (2001) Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 183(3):485–491CrossRefPubMed
36.
Parham NJ, Pollard SJ, Desvaux M, Scott-Tucker A, Liu C, Fivian A, Henderson IR (2005) Distribution of the serine protease autotransporters of the Enterobacteriaceae among extraintestinal clinical isolates of Escherichia coli. J Clin Microbiol 43(8):4076–4082CrossRefPubMed
37.
Pirotta M, Gunn J, Chondros P, Grover S, O’Malley P, Hurley S, Garland S (2004) Effect of Lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial. BMJ 329(7465):548CrossRefPubMed
38.
Reid G (2005) The importance of guidelines in the development and application of probiotics. Curr Pharm Des 11(1):11–16CrossRefPubMed
39.
Reid G, Zorzitto ML, Bruce AW, Jewett MAS, Chan RCY, Costerton JW (1984) The pathogenesis of urinary tract infection in the elderly: the role of bacterial adherence to uroepithelial cells. Curr Microbiol 11(2):67–72CrossRef
40.
Reid G, Cook RL, Bruce AW (1987) Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol 138(2):330–335PubMed
41.
Reid G, Bruce AW, Cook RL, Llano M (1990) Effect on the urogenital flora of antibiotic therapy for urinary tract infection. Scand J Infect Dis 22:43–47PubMedCrossRef
42.
Reid G, Bruce AW, Taylor M (1992) Influence of three day antimicrobial therapy and lactobacillus suppositories on recurrence of urinary tract infection. Clin Ther 14:11–16PubMed
43.
Reid G, Charbonneau-Smith R, Lam D, Lacerte M, Kang YS, Hayes KC (1992) Bacterial biofilm formation in the urinary bladder of spinal cord injured patients. Paraplegia 30:711–717PubMed
44.
Reid G, Bruce AW, Taylor M (1995) Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 23:32–45
45.
Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B (2001) Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 30(1):49–52CrossRefPubMed
46.
Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 35(2):131–134CrossRefPubMed
47.
Reid G, Hammond J-A, Bruce AW (2003) Effect of lactobacilli oral supplement on the vaginal microflora of antibiotic treated patients: randomized, placebo-controlled study. Nutraceut Food 8:145–148CrossRef
48.
Reid G, Kim SO, Kohler G (2005) Selection, testing and understanding probiotic microbes. FEMS Immunol Med Microbiol (in press)
49.
Seno Y, Kariyama R, Mitsuhata R, Monden K, Kumon H (2005) Clinical implications of biofilm formation by Enterococcus faecalis in the urinary tract. Acta Med Okayama 59:79–87PubMed
50.
Snyder JA, Haugen BJ, Lockatell CV, Maroncle N, Hagan EC, Johnson DE, Welch RA, Mobley HL (2005) Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect Immun 73(11):7588–7596CrossRefPubMed
51.
Strus M, Kucharska A, Kukla G, Brzychczy-Wloch M, Maresz K, Heczko PB (2005) The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol 13(2):69–75CrossRefPubMed
52.
Usein CR, Damian M, Tatu-Chitoiu D, Capusa C, Fagaras R, Mircescu G (2003) Comparison of genomic profiles of Escherichia coli isolates from urinary tract infections. Roum Arch Microbiol Immunol 62(3–4):137–154PubMed
53.
Velraeds MC, van der Belt B, van der Mei HC, Reid G, Busscher HJ (1998) Interference in initial adhesion of uropathogenic bacteria and yeasts silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol 49:790–794
Metadaten
Titel
Probiotics to prevent urinary tract infections: the rationale and evidence
verfasst von
Gregor Reid
Andrew W. Bruce
Publikationsdatum
01.02.2006
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 1/2006
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-005-0043-1

Weitere Artikel der Ausgabe 1/2006

World Journal of Urology 1/2006 Zur Ausgabe

Original Article

Retroperitoneoscopic donor nephrectomy: donor outcome and complication rate in comparison with three different techniques

Topic Paper

Chlamydial infections in urology

Topic Paper

Chronic pelvic pain syndrome/chronic prostatitis affect the acrosome reaction in human spermatozoa

Topic Paper

Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysaccharide-induced cystitis

Topic Paper

Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract

Topic Paper

The role of nanobacteria in urologic disease

Neu im Fachgebiet Urologie

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise